These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 1847758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.
    Lewis TA, Bayless L, DiPesa AJ, Eckman JB, Gillard M, Libertine L, Scannell RT, Wypij DM, Young MA.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1083-5. PubMed ID: 15686917
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor.
    Shirumalla RK, Sharma P, Dastidar SG, Paliwal JK, Kakar S, Varshney B, Singh Saini G, Sattigeri V, Salman M, Ray A.
    Inflamm Res; 2008 Mar 15; 57(3):135-43. PubMed ID: 18369577
    [Abstract] [Full Text] [Related]

  • 5. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase.
    Kimble E, Kowalski T, White D, Raychauduri A, Pastor G, Chertock H, Lee W, Neale R, Hamdan A, Wasley J.
    Agents Actions; 1991 Sep 15; 34(1-2):125-8. PubMed ID: 1665286
    [Abstract] [Full Text] [Related]

  • 6. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
    Hsu MF, Chang LC, Huang LJ, Kuo SC, Lee HY, Lu MC, Wang JP.
    Eur J Pharmacol; 2009 Apr 01; 607(1-3):234-43. PubMed ID: 19232341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors.
    Stewart AO, Bhatia PA, Martin JG, Summers JB, Rodriques KE, Martin MB, Holms JH, Moore JL, Craig RA, Kolasa T, Ratajczyk JD, Mazdiyasni H, Kerdesky FA, DeNinno SL, Maki RG, Bouska JB, Young PR, Lanni C, Bell RL, Carter GW, Brooks CD.
    J Med Chem; 1997 Jun 20; 40(13):1955-68. PubMed ID: 9207936
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Soy lipoxygenase as the object for the primary testing of potential inhibitors of leukotriene biosynthesis].
    Lototskaia LS, Naĭdenova IIu, Il'iasheva LM, Poda GI, Kornilov AI.
    Farmakol Toksikol; 1989 Jun 20; 52(2):59-62. PubMed ID: 2501105
    [Abstract] [Full Text] [Related]

  • 13. Blockade of cytosolic phospholipase A(2) and 5-lipoxygenase activation in neutrophils by a natural isoflavanquinone abruquinone A.
    Hsu MF, Chang LC, Chen SC, Kuo SC, Lee HY, Lu MC, Wang JP.
    Eur J Pharmacol; 2008 Nov 19; 598(1-3):123-31. PubMed ID: 18834875
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS).
    Terao S, Ohkawa S, Terashita Z, Shibouta Y, Nishikawa K.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Nov 19; 21A():173-6. PubMed ID: 1847762
    [No Abstract] [Full Text] [Related]

  • 15. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
    Liles WC, Meier KE, Henderson WR.
    J Immunol; 1987 May 15; 138(10):3396-402. PubMed ID: 3033073
    [Abstract] [Full Text] [Related]

  • 16. Benzothiazole hydroxy ureas as inhibitors of 5-lipoxygenase: use of the hydroxyurea moiety as a replacement for hydroxamic acid.
    Greco MN, Hageman WE, Powell ET, Tighe JJ, Persico FJ.
    J Med Chem; 1992 Aug 21; 35(17):3180-3. PubMed ID: 1324317
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA, Brooks CD, Basha A, Ratajczyk JD, Gunn BP, Bouska JB, Lanni C, Young PR, Bell RL, Carter GW.
    J Med Chem; 1996 Sep 27; 39(20):3938-50. PubMed ID: 8831760
    [Abstract] [Full Text] [Related]

  • 19. Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.
    Satoh Y, Stanton JL, Hutchison AJ, Libby AH, Kowalski TJ, Lee WH, White DH, Kimble EF.
    J Med Chem; 1993 Nov 12; 36(23):3580-94. PubMed ID: 8246226
    [Abstract] [Full Text] [Related]

  • 20. WY-50,295 tromethamine: a novel inhibitor of leukotriene-mediated reactions.
    Weichman BM, Berkenkopf JW, Grimes D, Heaslip RJ, Sturm RJ, Chang JY.
    Adv Prostaglandin Thromboxane Leukot Res; 1991 Nov 12; 21A():477-80. PubMed ID: 1847784
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.